Bisphosphonate therapy and atypical fractures.
review · Level V
Where this comes from
- Record sourced from PubMed, PMID 23544820.
- Also identified by DOI 10.1016/j.ocl.2013.01.001.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Atypical femoral fractures have attracted a great deal of attention and controversy in the osteoporosis community because of their association with prolonged bisphosphonate therapy. The purpose of this article is to review the epidemiologic evidence linking bisphosphonates to atypical fractures and to highlight the potential pathologic mechanisms involved in such fractures. A management plan is provided based on the available evidence.
Medical subject headings
- Diphosphonates
- Femoral Fractures
- Hip Fractures
- Osteoporosis
Anatomy
- femur
- hip